BioStem Technologies, Inc. (BSEM)
6.24
-0.48
(-7.14%)
USD |
OTCM |
Feb 06, 16:00
BioStem Technologies EPS Diluted (Quarterly) : 0.0328 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Plus Therapeutics, Inc. | -0.0412 |
| Iovance Biotherapeutics, Inc. | -0.2507 |
| Protokinetix, Inc. | -0.0002 |
| GB Sciences, Inc. | -0.0002 |
| Travere Therapeutics, Inc. | 0.2505 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 0.7611M |
| Revenue (Quarterly) | 10.47M |
| Total Expenses (Quarterly) | 9.712M |
| Enterprise Value | 80.84M |
| Gross Profit Margin (Quarterly) | 87.95% |
| Profit Margin (Quarterly) | 7.27% |
| Earnings Yield | 13.64% |
| Operating Earnings Yield | 11.02% |
| Normalized Earnings Yield | 13.64 |